DE602004025017D1 - C1ckb-mutation als diagnostisches und therapeutisches ziel - Google Patents

C1ckb-mutation als diagnostisches und therapeutisches ziel

Info

Publication number
DE602004025017D1
DE602004025017D1 DE602004025017T DE602004025017T DE602004025017D1 DE 602004025017 D1 DE602004025017 D1 DE 602004025017D1 DE 602004025017 T DE602004025017 T DE 602004025017T DE 602004025017 T DE602004025017 T DE 602004025017T DE 602004025017 D1 DE602004025017 D1 DE 602004025017D1
Authority
DE
Germany
Prior art keywords
nucleic acid
acid molecule
clckb
allergy
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004025017T
Other languages
English (en)
Inventor
Florian Lang
Siegfried Waldegger
Philipp Lang
Angelika Lampert
Hannsjoerg Seybert
Nikola Dr Jeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eberhard Karls Universitaet Tuebingen
Universitaetsklinikum Tuebingen
Original Assignee
Eberhard Karls Universitaet Tuebingen
Universitaetsklinikum Tuebingen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eberhard Karls Universitaet Tuebingen, Universitaetsklinikum Tuebingen filed Critical Eberhard Karls Universitaet Tuebingen
Publication of DE602004025017D1 publication Critical patent/DE602004025017D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
DE602004025017T 2003-10-15 2004-10-07 C1ckb-mutation als diagnostisches und therapeutisches ziel Active DE602004025017D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/687,523 US7074573B2 (en) 2003-10-15 2003-10-15 CLCKb mutation as a diagnostic therapeutical target
PCT/EP2004/011192 WO2005040417A1 (en) 2003-10-15 2004-10-07 C1CKb MUTATION AS A DIAGNOSTIC AND THERAPEUTICAL TARGET

Publications (1)

Publication Number Publication Date
DE602004025017D1 true DE602004025017D1 (de) 2010-02-25

Family

ID=34520994

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004025017T Active DE602004025017D1 (de) 2003-10-15 2004-10-07 C1ckb-mutation als diagnostisches und therapeutisches ziel

Country Status (5)

Country Link
US (2) US7074573B2 (de)
EP (1) EP1673474B1 (de)
AT (1) ATE454472T1 (de)
DE (1) DE602004025017D1 (de)
WO (1) WO2005040417A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1304768B1 (it) * 1998-10-05 2001-03-29 Esaote Spa Lettino porta paziente o simili, e macchina, in particolare macchinaper il rilevamento d'immagini in risonanza magnetica nucleare in
DE102005025799A1 (de) * 2005-06-02 2006-12-21 Eberhard-Karls-Universität Tübingen Verfahren zur Diagnose eines gestörten Magnesiumkanals
WO2011082382A2 (en) * 2009-12-31 2011-07-07 The Trustees Of Columbia University In The City Of New York Methods for detecting and regulating alopecia areata and gene cohorts thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016909A1 (en) 1997-10-01 1999-04-08 Yale University Methods to modulate blood pressure and diagnose bartter's syndrome type iii
AU2001249446A1 (en) 2000-03-24 2001-10-08 Dzgenes, L.L.C. Diagnostic polymorphisms of tgf-beta-rii promoter

Also Published As

Publication number Publication date
EP1673474B1 (de) 2010-01-06
US20050084485A1 (en) 2005-04-21
ATE454472T1 (de) 2010-01-15
EP1673474A1 (de) 2006-06-28
US7074573B2 (en) 2006-07-11
WO2005040417A1 (en) 2005-05-06
US20060240459A1 (en) 2006-10-26
US7235364B2 (en) 2007-06-26

Similar Documents

Publication Publication Date Title
BR9814276A (pt) Antìgenos de superfìcie
ATE353914T1 (de) Peptide zur behandlung von tumoren und anderen bedingungen die die entfernung oder zerstörung von zelle erfordern
ATE365213T1 (de) Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
BRPI0413076B8 (pt) processo analítico para composições de pancreatina e comparáveis
DE602004009705D1 (de) Methoden der Verhinderung und Behandlung der Alzheimer'schen Krankheit
CY1111120T1 (el) Πεπτιδια που παραγονται απο πρωτεϊνες νευρικων ινων και η ιατρικη τους χρηση
DK2157192T3 (da) Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner)
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
RS92704A (en) Immunoglobulin-domain containing cell surface recognition molecules
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
EE200100472A (et) Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks
BR0215284A (pt) Polipeptìdeo, fragmento ou equivalente funcional, molécula de ácido nucléico purificada, vetor, célula hospedeira, ligando, composto, método para diagnosticar uma doença em um paciente, uso de um polipeptìdeo, composição farmacêutica, composição de vacina, método para tratar uma doença em um paciente, método para monitorar o tratamento terapêutico de doença em um paciente, método para a identificação de um composto, kit, animal não humano transgênico ou de inativação, e, método para triar um composto efetivo para tratar doença
WO1998011234A3 (en) Human protein kinases
DE602004025017D1 (de) C1ckb-mutation als diagnostisches und therapeutisches ziel
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
EA200501711A1 (ru) Семейство секретируемых белков
IL169256A (en) Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
Shibata et al. Disruption of structural and functional integrity of α2‐macroglobulin by cathepsin E
BRPI0408510A (pt) métodos de identificar um membro da famìlia secfam1, de diagnosticar e de tratar uma doença em um paciente, de monitorar o tratamento terapêutico de doença em um paciente, de identificar um composto, e de triar quanto a um composto eficaz para tratar doença, polipeptìdeo, molécula de ácido nucleico purificada, vetor, célula hospedeira, ligando, composto, uso de um polipeptìdeo, composição farmacêutica, composição de vacima, kit, e, animal não humano transgênico ou de abatimento
SE0002189D0 (sv) New method and assay
WO2004038036A3 (en) Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
WO2003087408A3 (en) Schizophrenia associated genes
EP0855442A3 (de) Zentralnervensystemtranskriptionsregulatorpolypeptide und DNS Sequenz womit das Protein das diese Polypeptide enthält bindet
ATE465175T1 (de) Neuer proteinkomplex und anwendungen davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition